Keson-Brookes Maiken
Insider CIK 1693805 · QURE General Counsel · RUBY CLO & Corp. Secretary · MURA See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MURA Mural Oncology plc | D To issuer deriv | 2025-12-05 | 2025-12-05 | 65,000 | — | $0 | 0 | SEC↗ |
| MURA Mural Oncology plc | D To issuer deriv | 2025-12-05 | 2025-12-05 | 31,200 | — | $0 | 0 | SEC↗ |
| MURA Mural Oncology plc | D To issuer deriv | 2025-12-05 | 2025-12-05 | 54,242 | — | $0 | 0 | SEC↗ |
| MURA Mural Oncology plc | D To issuer | 2025-12-05 | 2025-12-05 | 68,834 | — | $0 | 0 | SEC↗ |
| MURA Mural Oncology plc | S Sale | 2025-07-22 | 2025-07-23 | 2,572 | $2.48 | $6.4K | 68,834 | SEC↗ |
| MURA Mural Oncology plc | S Sale | 2025-07-18 | 2025-07-22 | 2,158 | $2.48 | $5.4K | 71,406 | SEC↗ |
| MURA Mural Oncology plc | S Sale | 2025-03-05 | 2025-03-05 | 1,469 | $3.45 | $5.1K | 73,564 | SEC↗ |
| MURA Mural Oncology plc | S Sale | 2025-03-04 | 2025-03-05 | 1,262 | $3.36 | $4.2K | 75,033 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2025-03-03 | 2025-03-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| MURA Mural Oncology plc | A Award | 2025-03-03 | 2025-03-05 | 35,000 | — | $0 | 76,295 | SEC↗ |
| MURA Mural Oncology plc | S Sale | 2024-12-23 | 2024-12-26 | 2,555 | $3.27 | $8.4K | 41,295 | SEC↗ |
| MURA Mural Oncology plc | S Sale | 2024-07-18 | 2024-07-18 | 2,157 | $3.41 | $7.4K | 43,850 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2024-03-01 | 2024-03-04 | 31,200 | — | $0 | 31,200 | SEC↗ |
| MURA Mural Oncology plc | A Award | 2024-03-01 | 2024-03-04 | 16,800 | — | $0 | 46,007 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2023-12-14 | 2023-12-18 | 54,242 | — | $0 | 54,242 | SEC↗ |
| MURA Mural Oncology plc | A Award | 2023-12-14 | 2023-12-18 | 29,207 | — | $0 | 29,207 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2022-02-01 | 2022-02-01 | 2,732 | $6.57 | $17.9K | 5,343 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-01 | 34,500 | — | $0 | 34,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-01 | 143,750 | — | $0 | 143,750 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2022-01-29 | 2022-02-01 | 8,075 | — | $0 | 24,225 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2022-01-29 | 2022-02-01 | 8,075 | — | $0 | 8,075 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2021-03-15 | 2021-03-15 | 25,000 | — | $0 | 225,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2021-03-15 | 2021-03-15 | 25,000 | $7.70 | $192.5K | 25,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2021-03-15 | 2021-03-15 | 25,000 | $20.24 | $506.0K | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2021-01-29 | 2021-02-02 | 32,300 | — | $0 | 32,300 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2021-01-29 | 2021-02-02 | 142,500 | — | $0 | 142,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2019-11-29 | 2019-12-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2017-01-27 | 2017-01-31 | 43,250 | — | $0 | 43,250 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2017-01-27 | 2017-01-31 | 43,250 | — | $0 | 43,250 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2017-01-27 | 2017-02-21 | 43,500 | — | $0 | 43,500 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2017-01-27 | 2017-02-21 | 43,000 | — | $0 | 43,000 | SEC↗ |